—
DRUG
ValuationN/A
Cash flow & growthN/A
Upside potentialN/A
Risk potentialN/A
DRUG vs Historical averages
| Metric | Current | Average | Relative |
|---|---|---|---|
| EPS | -$2.00 | -$2.14 | $0.15 higher |
| FCF | -$18.1M | -$6M | -$12.1M |
| Loading historical comparisons… | |||
DRUG’s earnings are above their historical averages.
DRUG Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Loss widening |
| Forward revenue | -- |
| Forward profitability | -- |
| Analyst coverage | Limited |
| Estimate dispersion | Moderate |
DRUG’s available outlook is mixed, with weaker expected earnings weighing on the picture.
DRUG PE Valuation
Loading pe valuation table…
This table applies DRUG's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
DRUG Earnings Per Share
Loading earnings per share…
This chart tracks DRUG's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
DRUG Quarterly Revenue
Loading quarterly revenue…
This chart tracks DRUG's quarterly revenue over time and shows how sales are changing from year to year.
DRUG Free Cash Flow
Loading free cash flow…
This chart tracks DRUG's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
DRUG Total Shares
This chart tracks changes in DRUG's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
DRUG Net Leverage
Loading net leverage…
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
DRUG PE vs Healthcare Sector
Loading pe vs sector average…
This chart compares DRUG's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
DRUG Weekly Price
Loading weekly price…
This chart uses DRUG's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
DRUG Weekly Moving Averages
Loading weekly moving averages…
This chart compares DRUG's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
DRUG Yearly ROI
Loading yearly ROI…
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.